Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment

Clinical and Experimental Rheumatology

Volumn 27, Issue 5, 2009, Pages 890-891

  Cantarini, L ^a   Lucherini, O M ^a   Galeazzi, M ^a   Fanti, F ^b   Simonini, G ^b   Baldari, C T ^a   Laghi Pasini, F ^a   De Martino, M ^b   Cimaz, R ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ETANERCEPT; GLUTAMIC ACID; PREDNISONE;

AMINO ACID SUBSTITUTION; CASE REPORT; CHILD; CLINICAL FEATURE; DNA DETERMINATION; DRUG EFFICACY; DRUG WITHDRAWAL; EXON; FEMALE; GENE; GENE MUTATION; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; TNFRSF1A GENE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

CHILD; FEMALE; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SYNDROME;

EID: 72949102811     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. MCDERMOTT MF, AKSENTIJEVICH I, GALON J et al.: Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 133-144
2. D'OSUALDO A, FERLITO F, PRIGIONE I et al.: Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 2006; 54: 998-1008.
3. LOBITO AA, KIMBERLEY FC, MUPPIDI JR et al.: Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 2006; 108: 1320-1327
4. AKSENTIJEVICH I, GALON J, SOARES M et al.: The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001; 69: 301-314
5. GATTORNO M, SORMANI MP, D'OSUALDO A et al.: A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 2008; 58: 1823-1832
6. KALLINICH T, BRIESE S, ROESLER J et al.: Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSFlA gene associated with severe multiorganic amyloidosis. J Rheumatol 2004; 31: 2519-2522
7. DODÉ C, ANDRÉ M, BIENVENU T et al.: THE FRENCH HERADITARY RECURRENT INFLAMMATORY DISORDER STUDY GROUP. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2002; 46: 2181-2188
8. DREWE E, POWELL RJ: Novel treatments for tumor necrosis factor receptor-associated periodic syndrome (TRAPS): case history of experience with infliximab and sirolimus post etanercept. Clin Exp Rheumatol 2002; 20 (Suppl. 26): S71.
9. STOJANOV S, DEJACO C, LOHSE P et al.: Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 2008; 67: 1292-1298
10. DREWE E, LANYON PC, POWELL RJ: Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al. and Dode et al. Arthritis Rheum 2003; 48: 1769-1770